Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Weight Loss
- Sponsor
- Stanford University
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Amount of Weight Lost (kg)
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Detailed Description
Continuous glucose monitoring (CGM) has revolutionized the treatment of patients on intensive insulin therapy and its utility can also be harnessed to help individuals with prediabetes make healthful lifestyle changes. Successful weight loss requires adherence to lower calories, regular exercise, and self-monitoring. This proposal will test the hypothesis that intermittent CGM will facilitate all of these components for successful weight loss by functioning as a continuous self-monitor and guiding healthful food choices and physical activity.
Investigators
Sun H Kim
Associate Professor
Stanford University
Eligibility Criteria
Inclusion Criteria
- •Overweight/obese (BMI 25-40 kg/m2)
- •Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
Exclusion Criteria
- •On glucose-lowering medications (e.g., metformin)
- •On weight-loss medications
Outcomes
Primary Outcomes
Amount of Weight Lost (kg)
Time Frame: Baseline to end of study (3 months)
Weight lost during the study
Secondary Outcomes
- Number of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or More(Baseline to end of study (3 months))